LAWSON, John David,SABAT, Mark,SCORAH, Nicholas,SMITH, Christopher,VU, Phong H.,WANG, Haixia
申请号：
MEP201798
公开号：
ME02693B
申请日:
2014.03.10
申请国别(地区):
ME
年份:
2017
代理人:
摘要：
Disclosed are compounds of Formula 1, or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , and R 4 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating Type I hypersensitivity reactions, autoimmune diseases, inflammatory disorders, cancer, non-malignant proliferative disorders, and other conditions associated with BTK.
